# Debate on access to new medicines and quality of care

> An opinion piece argues that the quality of care should not be measured solely by access to new medicines, while the pharmaceutical industry calls for faster authorizations. The debate takes place during the examination of the Social Security Financing Bill (PLFSS) in Parliament.

**In brief**: Health event (severity: notable) nationwide, first detected on 16 November 2026 at 14:00. Reported by 1 source (1 article), last updated on 16 November 2026 at 14:00.

- Category: Health
- Severity: Notable
- Place: Nationwide
- First detected: 16 November 2026 at 14:00
- Updated: 16 November 2026 at 14:00
- Web page: https://acturadar.com/en/events/21789-debate-on-access-to-new-medicines-and-quality-of-care

## Sources (1 articles)

- [En France, la qualité des soins ne saurait se mesurer à l’accès aux nouveaux médicaments](https://www.lemonde.fr/idees/article/2026/11/16/en-france-la-qualite-des-soins-ne-saurait-se-mesurer-a-l-acces-aux-nouveaux-medicaments_6811771_3232.html) — Le Monde, 16 November 2026 at 14:00

---

Cite as: Acturadar, “Debate on access to new medicines and quality of care”, https://acturadar.com/en/events/21789-debate-on-access-to-new-medicines-and-quality-of-care
Methodology: https://acturadar.com/en/methodology
